 | • レポートコード：MRC2102QY5764 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の胃不全麻痺薬市場について種類別（運動促進剤、制吐剤、その他）、用途別（糖尿病性胃不全麻痺、特発性胃不全麻痺）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・胃不全麻痺薬市場の概要 ・世界の主要地域別胃不全麻痺薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の胃不全麻痺薬市場規模2015-2026：種類別（運動促進剤、制吐剤、その他） ・世界の胃不全麻痺薬市場規模2015-2026：用途別（糖尿病性胃不全麻痺、特発性胃不全麻痺） ・胃不全麻痺薬の米国市場規模2015-2020 ・胃不全麻痺薬のヨーロッパ市場規模2015-2020 ・胃不全麻痺薬の中国市場規模2015-2020 ・胃不全麻痺薬の日本市場規模2015-2020 ・胃不全麻痺薬の東南アジア市場規模2015-2020 ・胃不全麻痺薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・胃不全麻痺薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・胃不全麻痺薬の市場動向・機会・課題 ・調査の結論 |
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
Market Analysis and Insights: Global Gastroparesis Drugs Market
The global Gastroparesis Drugs market size is projected to reach US$ 6984.9 million by 2026, from US$ 5438.2 million in 2020, at a CAGR of 4.3% during 2021-2026.
Global Gastroparesis Drugs Scope and Market Size
The global Gastroparesis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastroparesis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Gastroparesis Drugs market is segmented into
Prokinetic Agents
Antiemetic Agents
Others
Segment by Application, the Gastroparesis Drugs market is segmented into
Diabetic Gastroparesis
Idiopathic Gastroparesis
The Gastroparesis Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Gastroparesis Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Gastroparesis Drugs Market Share Analysis
Gastroparesis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Gastroparesis Drugs business, the date to enter into the Gastroparesis Drugs market, Gastroparesis Drugs product introduction, recent developments, etc.
The major vendors covered:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
1 Gastroparesis Drugs Market Overview
1.1 Gastroparesis Drugs Product Scope
1.2 Gastroparesis Drugs Segment by Type
1.2.1 Global Gastroparesis Drugs Sales by Type (2020-2026)
1.2.2 Prokinetic Agents
1.2.3 Antiemetic Agents
1.2.4 Others
1.3 Gastroparesis Drugs Segment by Application
1.3.1 Global Gastroparesis Drugs Sales Comparison by Application (2020-2026)
1.3.2 Diabetic Gastroparesis
1.3.3 Idiopathic Gastroparesis
1.4 Gastroparesis Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Gastroparesis Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Gastroparesis Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Gastroparesis Drugs Price Trends (2015-2026)
2 Gastroparesis Drugs Estimate and Forecast by Region
2.1 Global Gastroparesis Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Gastroparesis Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Gastroparesis Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Gastroparesis Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Gastroparesis Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Gastroparesis Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Gastroparesis Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Gastroparesis Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Gastroparesis Drugs Estimates and Projections (2015-2026)
2.4.3 China Gastroparesis Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Gastroparesis Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Gastroparesis Drugs Estimates and Projections (2015-2026)
2.4.6 India Gastroparesis Drugs Estimates and Projections (2015-2026)
3 Global Gastroparesis Drugs Competition Landscape by Players
3.1 Global Top Gastroparesis Drugs Players by Sales (2015-2020)
3.2 Global Top Gastroparesis Drugs Players by Revenue (2015-2020)
3.3 Global Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroparesis Drugs as of 2019)
3.4 Global Gastroparesis Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Gastroparesis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Gastroparesis Drugs Players (Opinion Leaders)
4 Global Gastroparesis Drugs Market Size by Type
4.1 Global Gastroparesis Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Gastroparesis Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Gastroparesis Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Gastroparesis Drugs Price by Type (2015-2020)
4.2 Global Gastroparesis Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Gastroparesis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Gastroparesis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Gastroparesis Drugs Price Forecast by Type (2021-2026)
5 Global Gastroparesis Drugs Market Size by Application
5.1 Global Gastroparesis Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Gastroparesis Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Gastroparesis Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Gastroparesis Drugs Price by Application (2015-2020)
5.2 Global Gastroparesis Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Gastroparesis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Gastroparesis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Gastroparesis Drugs Price Forecast by Application (2021-2026)
6 United States Gastroparesis Drugs Market Facts & Figures
6.1 United States Gastroparesis Drugs Sales Market Share by Company (2015-2020)
6.2 United States Gastroparesis Drugs Sales Market Share by Type (2015-2020)
6.3 United States Gastroparesis Drugs Sales Market Share by Application (2015-2020)
7 Europe Gastroparesis Drugs Market Facts & Figures
7.1 Europe Gastroparesis Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Gastroparesis Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Gastroparesis Drugs Sales Market Share by Application (2015-2020)
8 China Gastroparesis Drugs Market Facts & Figures
8.1 China Gastroparesis Drugs Sales Market Share by Company (2015-2020)
8.2 China Gastroparesis Drugs Sales Market Share by Type (2015-2020)
8.3 China Gastroparesis Drugs Sales Market Share by Application (2015-2020)
9 Japan Gastroparesis Drugs Market Facts & Figures
9.1 Japan Gastroparesis Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Gastroparesis Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Gastroparesis Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Gastroparesis Drugs Market Facts & Figures
10.1 Southeast Asia Gastroparesis Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Gastroparesis Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Gastroparesis Drugs Sales Market Share by Application (2015-2020)
11 India Gastroparesis Drugs Market Facts & Figures
11.1 India Gastroparesis Drugs Sales Market Share by Company (2015-2020)
11.2 India Gastroparesis Drugs Sales Market Share by Type (2015-2020)
11.3 India Gastroparesis Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Gastroparesis Drugs Business
12.1 Sumitomo
12.1.1 Sumitomo Corporation Information
12.1.2 Sumitomo Business Overview
12.1.3 Sumitomo Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sumitomo Gastroparesis Drugs Products Offered
12.1.5 Sumitomo Recent Development
12.2 Cadila Pharmaceuticals
12.2.1 Cadila Pharmaceuticals Corporation Information
12.2.2 Cadila Pharmaceuticals Business Overview
12.2.3 Cadila Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cadila Pharmaceuticals Gastroparesis Drugs Products Offered
12.2.5 Cadila Pharmaceuticals Recent Development
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Business Overview
12.3.3 Sanofi Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Gastroparesis Drugs Products Offered
12.3.5 Sanofi Recent Development
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Business Overview
12.4.3 Teva Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Teva Gastroparesis Drugs Products Offered
12.4.5 Teva Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Corporation Information
12.5.2 Johnson & Johnson Business Overview
12.5.3 Johnson & Johnson Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Gastroparesis Drugs Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Pfizer Gastroparesis Drugs Products Offered
12.6.5 Pfizer Recent Development
12.7 Kyowa Kirin Pharmaceuticals
12.7.1 Kyowa Kirin Pharmaceuticals Corporation Information
12.7.2 Kyowa Kirin Pharmaceuticals Business Overview
12.7.3 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Products Offered
12.7.5 Kyowa Kirin Pharmaceuticals Recent Development
12.8 Hanmi Pharm
12.8.1 Hanmi Pharm Corporation Information
12.8.2 Hanmi Pharm Business Overview
12.8.3 Hanmi Pharm Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hanmi Pharm Gastroparesis Drugs Products Offered
12.8.5 Hanmi Pharm Recent Development
12.9 Ani Pharmaceuticals
12.9.1 Ani Pharmaceuticals Corporation Information
12.9.2 Ani Pharmaceuticals Business Overview
12.9.3 Ani Pharmaceuticals Gastroparesis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ani Pharmaceuticals Gastroparesis Drugs Products Offered
12.9.5 Ani Pharmaceuticals Recent Development
13 Gastroparesis Drugs Manufacturing Cost Analysis
13.1 Gastroparesis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Gastroparesis Drugs
13.4 Gastroparesis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Gastroparesis Drugs Distributors List
14.3 Gastroparesis Drugs Customers
15 Market Dynamics
15.1 Gastroparesis Drugs Market Trends
15.2 Gastroparesis Drugs Opportunities and Drivers
15.3 Gastroparesis Drugs Market Challenges
15.4 Gastroparesis Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Gastroparesis Drugs Sales (Kg) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Gastroparesis Drugs Sales (Kg) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Gastroparesis Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Gastroparesis Drugs Sales (Kg) by Region (2015-2020)
Table 5. Global Gastroparesis Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Gastroparesis Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Gastroparesis Drugs Revenue Share by Region (2015-2020)
Table 8. Global Gastroparesis Drugs Sales (Kg) Forecast by Region (2021-2026)
Table 9. Global Gastroparesis Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Gastroparesis Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Gastroparesis Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Gastroparesis Drugs (Kg) of Key Companies (2015-2020)
Table 13. Global Gastroparesis Drugs Sales Share by Company (2015-2020)
Table 14. Global Gastroparesis Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Gastroparesis Drugs Revenue Share by Company (2015-2020)
Table 16. Global Gastroparesis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastroparesis Drugs as of 2019)
Table 17. Global Gastroparesis Drugs Average Price (US$/mg) of Key Company (2015-2020)
Table 18. Manufacturers Gastroparesis Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Gastroparesis Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Gastroparesis Drugs Players
Table 22. Global Gastroparesis Drugs Sales (Kg) by Type (2015-2020)
Table 23. Global Gastroparesis Drugs Sales Share by Type (2015-2020)
Table 24. Global Gastroparesis Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Gastroparesis Drugs Price (Kg) by Type (2015-2020)
Table 26. Global Gastroparesis Drugs Sales Share by Type (2021-2026)
Table 27. Global Gastroparesis Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Gastroparesis Drugs Revenue Share by Type (2021-2026)
Table 29. Global Gastroparesis Drugs Price (Kg) by Type (2021-2026)
Table 30. Global Gastroparesis Drugs Sales (Kg) by Application (2015-2020)
Table 31. Global Gastroparesis Drugs Sales Share by Application (2015-2020)
Table 32. Global Gastroparesis Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Gastroparesis Drugs Price (Kg) by Application (2015-2020)
Table 34. Global Gastroparesis Drugs Sales (Kg) by Application (2021-2026)
Table 35. Global Gastroparesis Drugs Sales Share by Application (2021-2026)
Table 36. Global Gastroparesis Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Gastroparesis Drugs Revenue Share by Application (2021-2026)
Table 38. Global Gastroparesis Drugs Price (Kg) by Application (2021-2026)
Table 39. United States Gastroparesis Drugs Sales (Kg) by Company (2015-2020)
Table 40. United States Gastroparesis Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Gastroparesis Drugs Sales (Kg) by Type (2015-2020)
Table 42. United States Gastroparesis Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Gastroparesis Drugs Sales (Kg) by Application (2015-2020)
Table 44. United States Gastroparesis Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Gastroparesis Drugs Sales (Kg) by Company (2015-2020)
Table 46. Europe Gastroparesis Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Gastroparesis Drugs Sales (Kg) by Type (2015-2020)
Table 48. Europe Gastroparesis Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Gastroparesis Drugs Sales (Kg) by Application (2015-2020)
Table 50. Europe Gastroparesis Drugs Sales Market Share by Type (2015-2020)
Table 51. China Gastroparesis Drugs Sales (Kg) by Company (2015-2020)
Table 52. China Gastroparesis Drugs Sales Market Share by Company (2015-2020)
Table 53. China Gastroparesis Drugs Sales (Kg) by Type (2015-2020)
Table 54. China Gastroparesis Drugs Sales Market Share by Type (2015-2020)
Table 55. China Gastroparesis Drugs Sales (Kg) by Application (2015-2020)
Table 56. China Gastroparesis Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Gastroparesis Drugs Sales (Kg) by Company (2015-2020)
Table 58. Japan Gastroparesis Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Gastroparesis Drugs Sales (Kg) by Type (2015-2020)
Table 60. Japan Gastroparesis Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Gastroparesis Drugs Sales (Kg) by Application (2015-2020)
Table 62. Japan Gastroparesis Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Gastroparesis Drugs Sales (Kg) by Company (2015-2020)
Table 64. Southeast Asia Gastroparesis Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Gastroparesis Drugs Sales (Kg) by Type (2015-2020)
Table 66. Southeast Asia Gastroparesis Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Gastroparesis Drugs Sales (Kg) by Type (2015-2020)
Table 68. Southeast Asia Gastroparesis Drugs Sales Market Share by Application (2015-2020)
Table 69. India Gastroparesis Drugs Sales (Kg) by Company (2015-2020)
Table 70. India Gastroparesis Drugs Sales Market Share by Company (2015-2020)
Table 71. India Gastroparesis Drugs Sales (Kg) by Type (2015-2020)
Table 72. India Gastroparesis Drugs Sales Market Share by Type (2015-2020)
Table 73. India Gastroparesis Drugs Sales (Kg) by Application (2015-2020)
Table 74. India Gastroparesis Drugs Sales Market Share by Application (2015-2020)
Table 75. Sumitomo Corporation Information
Table 76. Sumitomo Description and Business Overview
Table 77. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 78. Sumitomo Gastroparesis Drugs Product
Table 79. Sumitomo Recent Development
Table 80. Cadila Pharmaceuticals Corporation Information
Table 81. Cadila Pharmaceuticals Description and Business Overview
Table 82. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 83. Cadila Pharmaceuticals Gastroparesis Drugs Product
Table 84. Cadila Pharmaceuticals Recent Development
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 88. Sanofi Gastroparesis Drugs Product
Table 89. Sanofi Recent Development
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 93. Teva Gastroparesis Drugs Product
Table 94. Teva Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Gastroparesis Drugs Product
Table 99. Johnson & Johnson Recent Development
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 103. Pfizer Gastroparesis Drugs Product
Table 104. Pfizer Recent Development
Table 105. Kyowa Kirin Pharmaceuticals Corporation Information
Table 106. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 107. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 108. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product
Table 109. Kyowa Kirin Pharmaceuticals Recent Development
Table 110. Hanmi Pharm Corporation Information
Table 111. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 112. Hanmi Pharm Description and Business Overview
Table 113. Hanmi Pharm Gastroparesis Drugs Product
Table 114. Hanmi Pharm Recent Development
Table 115. Ani Pharmaceuticals Corporation Information
Table 116. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (Million USD), Price (US$/mg) and Gross Margin (2015-2020)
Table 117. Ani Pharmaceuticals Description and Business Overview
Table 118. Ani Pharmaceuticals Gastroparesis Drugs Product
Table 119. Ani Pharmaceuticals Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Gastroparesis Drugs Distributors List
Table 123. Gastroparesis Drugs Customers List
Table 124. Gastroparesis Drugs Market Key Trends
Table 125. Gastroparesis Drugs Key Opportunities and Drivers
Table 126. Gastroparesis Drugs Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastroparesis Drugs Product Picture
Figure 2. Global Gastroparesis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Gastroparesis Drugs Market Share by Application in 2020 & 2026
Figure 6. Diabetic Gastroparesis Examples
Figure 7. Idiopathic Gastroparesis Examples
Figure 8. Global Gastroparesis Drugs Sales (Kg) Growth Rate (2015-2026)
Figure 9. Global Gastroparesis Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Gastroparesis Drugs Price Trends Growth Rate (2015-2026) (US$/mg)
Figure 11. Global Gastroparesis Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Gastroparesis Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Gastroparesis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Gastroparesis Drugs Sales (Kg) Growth Rate (2015-2026)
Figure 15. Europe Gastroparesis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Gastroparesis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Gastroparesis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Gastroparesis Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Gastroparesis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Gastroparesis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Gastroparesis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Gastroparesis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Gastroparesis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Gastroparesis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Gastroparesis Drugs Players Market Share by Revenue in Gastroparesis Drugs 2015 & 2019
Figure 26. Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Gastroparesis Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Gastroparesis Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Gastroparesis Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Gastroparesis Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Gastroparesis Drugs Sales Market Share by Type in 2019
Figure 32. United States Gastroparesis Drugs Sales Market Share by Type in 2019
Figure 33. Europe Gastroparesis Drugs Sales Market Share by Company in 2019
Figure 34. Europe Gastroparesis Drugs Sales Market Share by Type in 2019
Figure 35. Europe Gastroparesis Drugs Sales Market Share by Application in 2019
Figure 36. China Gastroparesis Drugs Sales Market Share by Company in 2019
Figure 37. China Gastroparesis Drugs Sales Market Share by Type in 2019
Figure 38. China Gastroparesis Drugs Sales Market Share by Application in 2019
Figure 39. Japan Gastroparesis Drugs Sales Market Share by Company in 2019
Figure 40. Japan Gastroparesis Drugs Sales Market Share by Type in 2019
Figure 41. Japan Gastroparesis Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Gastroparesis Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Gastroparesis Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Gastroparesis Drugs Sales Market Share by Application in 2019
Figure 45. India Gastroparesis Drugs Sales Market Share by Company in 2019
Figure 46. India Gastroparesis Drugs Sales Market Share by Type in 2019
Figure 47. India Gastroparesis Drugs Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Gastroparesis Drugs
Figure 50. Manufacturing Process Analysis of Gastroparesis Drugs
Figure 51. Gastroparesis Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …- トレプロスチニル薬の世界市場レポート2020 Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8…
- 副腎白質ジストロフィー治療薬の世界市場レポート2020 Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a peroxisomal protein called adrenoleukodystrophy protein (ALDP). Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatt…
- 非ステロイド性抗炎症薬の世界市場レポート2020 Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune dis…
- アルツハイマー病治療薬の世界市場レポート2020 Market Analysis and Insights: Global Alzheimer's Drugs Market The global Alzheimer's Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Alzheimer's Drugs Scope and Market Size The global Alzheimer's Drugs market is s…